Who are Adcendo ApS's investors?

Adcendo ApS's investors include Vida Ventures, HealthCap, Jeito Capital, Novo Holdings, OrbiMed, Pontifax Venture Capital, RA Capital, TCG Crossover and 2 more.

Where is Adcendo ApS headquartered?

Adcendo ApS is headquartered in Copenhagen, DK.

Adcendo ApS

Copenhagen, DK · 10 known investors

Find your way into Adcendo ApS

Paths you didn't know you had: your email and LinkedIn already hold routes to the Adcendo ApS team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.

Biotech Medical Devices

Founders & leadership

Michael Pehl, MScChief Executive Officer

Investors · 10

Vida Ventures✓ confirmed by Adcendo ApSLos Angeles

How we know: Vida Ventures's portfolio page · Not right? Tell us

HealthCaplisted by HealthCapStockholm

How we know: HealthCap's portfolio page · Not right? Tell us

Jeito Capitallisted by Jeito CapitalParis

Novo Holdingslisted by Novo HoldingsHellerup · $1.1M – $54M

How we know: Novo Holdings's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

OrbiMedlisted by OrbiMedNew York · $1M – $75M

How we know: OrbiMed's portfolio page · the VCSheet dataset · Not right? Tell us

Pontifax Venture Capitallisted by Pontifax Venture CapitalHerzeliya

How we know: Pontifax Venture Capital's portfolio page · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · Not right? Tell us

TCG Crossoverlisted by TCG CrossoverPalo Alto

Gilde HealthcarereportedUtrecht · $1.1M – $55M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

NVIDIAreportedSanta Clara

How we know: funding news · Not right? Tell us

Related companies · 2

AlumniAstraZeneca develops and markets pharmaceutical products, vaccines, and biologics across oncology, cardiovascular disease, respiratory and immunology, and rare disease areas, serving patients and healthcare providers globally.

Definitive HealthcareDefinitive Healthcare delivers market intelligence and data analytics on healthcare organizations, clinicians, and consumers, serving life sciences companies, healthcare providers, and other industries that interact with healthcare. The company provides data consolidation, analytics services, and digital advertising activation capabilities to help customers make informed decisions in the healthcare market.

Companies working in the same space as Adcendo ApS.

Frequently asked questions

What does Adcendo ApS do?: Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need. The company engineers therapeutic medicines designed to deliver clinically differentiated outcomes for cancer patients.
Who are Adcendo ApS's investors?: Adcendo ApS's investors include Vida Ventures, HealthCap, Jeito Capital, Novo Holdings, OrbiMed, Pontifax Venture Capital, RA Capital, TCG Crossover and 2 more.
Where is Adcendo ApS headquartered?: Adcendo ApS is headquartered in Copenhagen, DK.